LinkBack URL
About LinkBacksHealthDay - MONDAY, January 30 (HealthDay News) -- Erivedge (vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cell carcinoma, the agency said Monday.
More...
Erivedge Approved to Treat Basal Cell Carinoma (HealthDay) HealthDay - MONDAY, January 30 (HealthDay News) -- Erivedge (vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cell carcinoma, the agency said Monday.
More...
Posting Permissions
Reply With Quote